Anala Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.98 M
- Company Age 31 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Satisfied Charges ₹ 0.34 M
About Anala Pharmaceuticals
Anala Pharmaceuticals Pvt Ltd (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 November 1993 and has a history of 31 years and three months. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.98 M.
The company currently has active open charges totaling ₹0.50 M. The company has closed loans amounting to ₹0.34 M, as per Ministry of Corporate Affairs (MCA) records.
Satheep Soman, Sabeesh Kumar, Biju Narayanan, and One other member serve as directors at the Company.
Company Details
-
Location
Thrissur, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231KL1993PTC007462
-
Company No.
007462
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Nov 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Anala Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ezhuthupurakkal Chandran
|
Managing Director | 30-Sep-1995 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Satheep Soman
|
Director | 26-May-2023 | Current |
|
Sabeesh Kumar
|
Director | 26-May-2023 | Current |
|
Biju Narayanan
|
Director | 26-May-2023 | Current |
Financial Performance of Anala Pharmaceuticals.
Anala Pharmaceuticals Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anala Pharmaceuticals?
In 2017, Anala Pharmaceuticals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.50 M
₹0.34 M
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2011 | Corporation Bank | ₹0.50 M | Open |
| 28 Nov 1994 | Catholic Syrian Bank Ltd. | ₹0.15 M | Satisfied |
| 20 Jul 1994 | Catholic Syrian Bank Ltd. | ₹0.19 M | Satisfied |
How Many Employees Work at Anala Pharmaceuticals?
Unlock and access historical data on people associated with Anala Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anala Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anala Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
